Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Nerve Stories

2013-08-15 23:20:55

Files second quarter 2013 quarterly report on Form 10-Q. Alachua, FL (PRWEB) August 15, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced the closing of an underwritten offering of 6,000,000 shares of its common stock at a price to the public of $3.00 per share. The Company received gross proceeds of approximately $18...

Understanding How Neurons Get Wired
2013-08-15 09:27:33

University of Arizona Two different versions of the same signaling protein tell a nerve cell which end is which, UA researchers have discovered. The findings could help improve therapies for spinal injuries and neurodegenerative diseases. University of Arizona scientists have discovered an unknown mechanism that establishes polarity in developing nerve cells. Understanding how nerve cells make connections is an important step in developing cures for nerve damage resulting from spinal...

2013-08-13 11:36:33

High-resolution multilayer X-ray computer tomography and 3.0T superconducting magnetic resonance myelography are known to obtain a more complete and continuous two-dimensional original data. Three-dimensional reconstruction nerve models are classically obtained from two-dimensional images of "visible human" frozen sections. However, because of the flexibility of nerve tissues and small color differences compared with surrounding tissues, the integrity and validity of nerve tissues can be...

2013-08-06 23:23:40

Nerve repair and protection company to provide company update at life sciences conference. Alachua, FL (PRWEB) August 06, 2013 AxoGen, Inc. (OTCQB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products for peripheral nerve reconstruction and regeneration, today announced that Chief Executive Officer, Karen Zaderej, is scheduled to present at the Wedbush 2013 Life Sciences Management Access Conference in New York. Event: Wedbush 2013 Life...

2013-07-29 23:00:44

Navy Corpsman injured while serving in Afghanistan Selected to Represent Tissue Recipients on the American Association of Tissue Bank’s “Donate Life” Float Alachua, FL (PRWEB) July 29, 2013 AxoGen, Inc. (OTCQB: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, today announced that Navy Corpsman Edward Bonfiglio, a patient who received limb sparing surgery...

2013-07-01 23:19:34

AxoGen CEO to provide Company Updates at JMP Securities Conference Alachua, FL (PRWEB) July 01, 2013 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that Karen Zaderej, President and Chief Executive Officer, is scheduled to present at the 8th Annual JMP Securities Healthcare Conference in New York. Event: The 8th Annual JMP...

2013-06-27 23:45:29

Regenerative medicine company to hold Shareholders' Meeting in Orlando. Alachua, FL (PRWEB) June 26, 2013 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, announced today that it will hold its Annual Shareholders’ Meeting (the “Meeting”) on Thursday, August 1, 2013 at 1:00 PM EST at the Hyatt Regency Orlando International Airport,...

2013-06-26 12:28:23

WASHINGTON, June 26, 2013 /PRNewswire-USNewswire/ -- Researchers at the Case Western Medical School and the Cleveland Clinic have developed a technique that regenerates nerve cells in rats, permitting them to urinate normally after severe spinal cord injury. The results of their research are published in today's edition of the Journal of Neuroscience. According to scientists Yu-Shang Lee and Jerry Silver, their technique raises hope that humans with such injuries may also be able to...

2013-06-04 23:21:26

New Products for Peripheral Nerve Repair and Protection to be available to Canadian Surgeons and Patients Alachua, FL (PRWEB) June 04, 2013 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced Health Canada Approval for AxoGuard® Nerve Connector and AxoGuard® Nerve Protector. The AxoGuard® Products, along with...

2013-05-29 23:20:02

Congress Focused on Nerve Repair in the Hand; Presentation to Highlight Use of Avance® Nerve Graft in Hand Microsurgery. Alachua, FL (PRWEB) May 29, 2013 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that positive data based on clinical use of Avance® Nerve Graft will be presented in an oral presentation at the 18th...